Latest News about BofA Securities
Recent news which mentions BofA Securities
From Benzinga
Qualcomm Beat Q1 Expectations: Why One Analyst Flags Huawei As A 'Key Risk Factor'
February 01, 2024
From Benzinga
From Benzinga
Bloom Energy Is Sapped By Low Visibility, Says Bearish Analyst
January 29, 2024
Tickers
BE
From Benzinga
From Benzinga
3M's Earnings Beat Not Enough: Analyst Stays Neutral After Disappointing Revenue Performance
January 23, 2024
From Benzinga
ADP Analyst Upgrades Stock Before Q2 Earnings, But Still Favors Visa And Mastercard
January 17, 2024
From Benzinga
This Apple Analyst Deep Dives Into Latest App Store Data
January 09, 2024
From Benzinga
Why This Teradyne Analyst Is Turning Bullish
December 15, 2023
From Benzinga
This Colgate-Palmolive Analyst Is Turning Bullish On Heels Of CBD, Dental Pain Study
December 15, 2023
Tickers
CL
From Benzinga
Why This Crocs Analyst Says Company Is Putting Its Best Foot Forward
December 12, 2023
Tickers
CROX
From Benzinga
Why This RBC Bearings Analyst Double Upgraded The Stock Wednesday
November 29, 2023
Tickers
RBC
From Benzinga
American Axle Investors Have A While To Wait For Positive Catalysts, Bearish Analyst Says
November 28, 2023
Tickers
AXL
From Benzinga
Why This Weatherford Analyst Is Bullish On Oil Play
November 10, 2023
From Benzinga
Take-Two Interactive Analysts Examine Q4: GTA 6 Trailer Will 'Remove Investor Worries'
November 09, 2023
Tickers
TTWO
From Benzinga
3 Of 4 Birkenstock Analysts Are Bullish: What Does BofA Securities Expect From Shoemaker?
November 06, 2023
Tickers
BIRK
From Benzinga
Roku Shares Jump After Q3 Delivers Many Positives: 7 Analysts Tune Into Into Print, Guide
November 02, 2023
Tickers
ROKU
From Benzinga
Chevron Stock Pullback Wipes Out 90% Of Hess Value, But This Bullish Analyst Says 'Buy'
October 30, 2023
From Benzinga
Intel Analysts Aren't Totally Impressed By Q3 Results: Nvidia May Be A Customer 'At Some Point'
October 27, 2023
From Benzinga
Meta Platforms Reports Solid Q3 Print, But Q4 Outlook Is A Concern: 7 Analysts Dive Deeper Into Results
October 26, 2023
From Benzinga
From Benzinga
From Benzinga
Eli Lilly's Upcoming Obesity Drugs Highlight Bright Future, Says Optimistic Analyst
October 06, 2023
Tickers
LLY
From Benzinga
Orange Has Juice: A Pending Masmovil Deal Is 'Most Anticipated Event This Year,' Analyst Says
October 04, 2023
Tickers
ORAN
From Benzinga
AB InBev Analyst Turns Bullish On Alcohol Giant's 'Business Transformation'
September 29, 2023
Tickers
BUD
From Benzinga
What 7 Analysts Think of Micron Technology's Q4: Excess Inventory, Product Demand
September 28, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.